Publications
Researchers Identify Novel Mutation in Melanoma Cancer Cells
In a recent study published in Science Signaling entitled “The E3 ligase APC/CCdh1 promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth“, scientists from the Boston University School of Medicine (BUSM) found that humans susceptible to develop melanoma cancer have lower levels of Cdh1, a tumor suppressor gene. This gene belongs to a protein complex called Anaphase-Promoting Complex (APC/C).
Sentinel Node Positivity Less Likely in Presence of Melanoma Regression
Metastasis to sentinel lymph nodes was significantly lower among patients with melanoma with histologic regression of their disease compared with those without regression, according to the results of a recently published meta-analysis.
Dabrafenib/Trametinib Combo Granted EU Approval for Advanced Melanoma
The combination of dabrafenib (Tafinlar) plus trametinib (Mekinist) has been approved by the European Commission for the treatment of patients with unresectable or metastatic BRAF V600–positive melanoma, according to a statement from the drugs’ developer, Novartis.